Metraipolis › archive › dc_9b77167fbc2a
Acceptability of a clofazimine tablet in children with rifampicin-resistant TB in three high-burden countries — Europe PMC PMID:40821683
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40821683
- DOI
- 10.5588/ijtldopen.25.0309
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T15:37:25.499Z
- SHA-256 of the archived text
f2309096d3c2eb0d848816d09f330664f161e817e726b12a0b377f33b9891491- Stable URL of this page
https://metraipolis.com/documento/dc_9b77167fbc2a
How to cite
Acceptability of a clofazimine tablet in children with rifampicin-resistant TB in three high-burden countries — Europe PMC PMID:40821683 — Europe PMC (en), https://europepmc.org/article/MED/40821683 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9b77167fbc2a (Metraipolis archive dc_9b77167fbc2a, sha256 f2309096d3c2eb0d848816d09f330664f161e817e726b12a0b377f33b9891491)
BibTeX
@misc{dc9b77167fbc2a,
title = {Acceptability of a clofazimine tablet in children with rifampicin-resistant TB in three high-burden countries — Europe PMC PMID:40821683},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40821683},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9b77167fbc2a; sha256 f2309096d3c2eb0d848816d09f330664f161e817e726b12a0b377f33b9891491},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40821683. Agents can read the archived copy with the MCP tool read_document.